Drug Shortage Report for 0.4% LIDOCAINE HYDROCHLORIDE AND 5% DEXTROSE INJECTION

Last updated on 2023-02-14 History
Report ID 179915
Drug Identification Number 00828602
Brand name 0.4% LIDOCAINE HYDROCHLORIDE AND 5% DEXTROSE INJECTION
Common or Proper name 0.4% LIDOCAINE HYDROCHLORIDE AND 5% DEXTROSE INJECTION
Company Name BAXTER CORPORATION
Market Status MARKETED
Active Ingredient(s) DEXTROSE LIDOCAINE HYDROCHLORIDE
Strength(s) 50MG 4MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 500mL bag
ATC code C01BB
ATC description ANTIARRHYTHMICS, CLASS I AND III
Reason for shortage Demand increase for the drug.
Anticipated start date 2023-01-09
Actual start date 2023-01-09
Estimated end date 2023-02-13
Actual end date 2023-02-13
Shortage status Resolved
Updated date 2023-02-14
Company comments Baxter product LIDOCAINE HYDROCHLORIDE 0.4% AND 5% DEXTROSE INJECTION (250 mL bags) is available as a substitute.
Health Canada comments
Tier 3 Status No
Contact Address 7125 MISSISSAUGA ROAD
MISSISSAUGA, ONTARIO
CANADA L5N 0C2
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2023-02-14 English Compare
v7 2023-02-13 French Compare
v6 2023-02-13 English Compare
v5 2023-02-06 French Compare
v4 2023-02-06 English Compare
v3 2023-01-10 English Compare
v2 2023-01-05 French Compare
v1 2023-01-05 English Compare

Showing 1 to 8 of 8